Company / Operating Income
Bionano Genomics, Inc. Operating Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$33.3M
FY2025
5-year range
-$215.2M / -$33.3M
FY2021-FY2025
Trend
+84.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$132M to -$33M over the past 2 years.
Based on SEC 10-K filings.
-$33M in FY2025.
Improved from -$132M to -$33M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 84.5% year-over-year.
- Peak operating income was recorded in FY2019.
- Lowest operating income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$33.3M | +84.5% |
| FY2024 | -$215.2M | -63.4% |
| FY2023 | -$131.7M | +0.0% |
| FY2022 | -$131.7M | -241.6% |
| FY2021 | -$38.6M | -49.0% |
| FY2020 | -$25.9M | -26.7% |
| FY2019 | -$20.4M | +12.1% |
| FY2018 | -$23.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026